Indiva Secures Agreement with CannMart
Indiva’s CBD Softgels and Indica Capsules available on CannMart by the end of August; Bhang® Chocolate and Wana™ Sour Gummies to follow
LONDON, Ontario – August 20, 2020: Indiva Limited (the “Company” or “Indiva”) (TSXV:NDVA) (OTCQX:NDVAF), a leading Canadian producer of cannabis edibles and other cannabis products, is pleased to announce its wholly owned subsidiary, Indiva Inc., has reached an agreement with CannMart Inc. (“CannMart”), a wholly owned subsidiary of Namaste Technologies Inc. (“Namaste”) (TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF). The agreement will see Indiva’s CBD Softgels and Indica Capsules available on CannMart’s B2C distribution channel for their medical customers by the end of August, with Bhang® Chocolate and Wana™ Sour Gummies to follow later in the year.
“CannMart is increasing its reach into the legal Canadian cannabis market and is a natural choice for our award-winning products,” said Niel Marotta, President and CEO, Indiva Limited. “Our softgels and capsules are highly regarded for their consistency and quality and will be available on the CannMart marketplace in late August. Later this fall we look forward to introducing our award-winning Bhang® Chocolate and WanaTM Sour Gummies to the CannMart product universe.”
“Indiva’s CBD Softgels, Indica Capsules along with Bhang® Chocolates and Wana™ Sour Gummies are a great addition to CannMart,” said Meni Morim, CEO of Namaste Technologies Inc. “We have made tremendous inroads in both the medical and recreational sales channels and the investment we made in our processing and distribution facilities has allowed us to expand our presence within the legal Canadian cannabis market. As we add more high-quality Cannabis 2.0 products from leading companies like Indiva, we look to drive additional customers, suppliers and revenue from CannMart. We are excited to add these high quality, innovative products to our Cannabis 2.0 category and will work with the Indiva team to grow the Indiva product offering on CannMart.”
Namaste is adding Indiva’s product line to CannMart, its online marketplace, as it continues to expand its Cannabis 2.0 product offering. CannMart is an online marketplace carrying a large selection of legal cannabis products and accessories from many of the best cannabis producers in Canada and around the world. It is focused on providing medical cannabis patients and adult-use enthusiasts with access to the highest quality cannabis products available. CannMart also prepares, packages and distributes cannabis products through strategic relationships with leading government agencies.
About Namaste Technologies Inc
With headquarters in Toronto, Canada, Namaste Technologies is a leading online platform for cannabis products, accessories, and responsible education. The company’s ‘everything cannabis store’, CannMart.com, provides customers with a diverse selection of hand-picked products from a multitude of federally-licensed cultivators, all on one convenient site. Namaste’s global technology and continuous innovation address local needs in a burgeoning cannabis industry requiring smart solutions. Information on the Company and its many products can be accessed through the links below:
Indiva sets the standard for quality and innovation in cannabis. As a Canadian licensed producer, Indiva creates premium pre-rolls, flower, capsules, and edible products and provides production and manufacturing services to peer entities. In Canada, Indiva produces and distributes the award-winning Bhang® Chocolate, WanaTM Sour Gummies, Ruby® Cannabis Sugar, Sapphire™ Cannabis Salt and other Powered by INDIVA™ products through license agreements, partnerships and joint ventures. Click here to connect with Indiva on LinkedIn, Instagram, Twitter and Facebook, and here to find more information on the Company and its products.
Meagan Kelly, Marketing and Communications Specialist
Disclaimer and Reader Advisory
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) has in any way passed upon the merits of the contents of this press release and neither of the foregoing entities accepts responsibility for the adequacy or accuracy of this release or has in any way approved or disapproved of the contents of this press release.
Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “could”, “intend”, “expect”, “believe”, “will”, “projected”, “estimated” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties’ current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, this release contains forward-looking information relating to the Company’s future operations, future product offerings and compliance with applicable regulations. Various assumptions or factors are typically applied in drawing conclusions or making the forecasts or projections set out in forward-looking information. Those assumptions and factors are based on information currently available to the parties. The material factors and assumptions include the parties being able to maintain the necessary regulatory and other third parties’ approvals and licensing and other risks associated with regulated entities in the cannabis industry. The forward-looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.
This press release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. The securities have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”) or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available. Not for distribution to U.S. Newswire Services or for dissemination in the United States. Any failure to comply with this restriction may constitute a violation of U.S. Securities laws.